Cipla , one of India's largest drugmaker by sales, reported a bigger-than-expected third-quarter profit on Tuesday, helped by ...
Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by ...
Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday, helped by ...
Discover the Cipla Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock.
Stay informed with the Cipla Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...
Motilal Oswal retains Neutral on Cipla; see limited upside due to delayed niche product approvals. Learn more about the ...
Cipla's oncology drug Abraxane will be launched from its Goa facility while respiratory drug Advair will be rolled out from ...
Preview: India's third largest pharmaceutical company, Cipla, is scheduled to deliver its October-December quarterly earnings ...
The reported net profit is higher with the Rs 1,225 crore average net profit estimated by 10 brokerages polled by ...
Cipla reported a 48.73% increase in consolidated net profit for Q3 2024. The growth was attributed to improved performance ...
The company reported a 48% year-on-year (y-o-y) jump in its consolidated net profit to ₹1,571 crore in October-December, ...
This achievement has been recognised by the Asia Book of Records for engaging the largest number of doctors in a COPD ...